Even though the levels or BST‐2 were high in these brain tumor cells, there was no therapeutic significance following RNAi‐mediated downregulation of BST‐2 or pretreatment of cells with anti‐BST‐2 mAb 128. Here, BST2 is linked to brain neoplasm.